Home journal
 

Keywords :   


Tag: journal

Dublin-based wireless broadband provider HIBB to offer 3Gbps service, journal says

2013-10-25 14:24:37| Wireless - Topix.net

SiliconRepublic reports that Dublin-based wireless services provider Host Ireland Business Broadband has morphed its business model, from pure hosting to offering businesses and other carriers high speed internet access at speeds ranging from 700Mbps to 3Gbps.

Tags: service offer journal wireless

 

Men's Wearhouse a suitor for Allen Edmonds?: Wall Street Journal

2013-10-23 05:42:27| Apparel - Topix.net

Port Washington-based Allen Edmonds, the maker of high-end men's dress shoes, is owned by private equity firm Goldner Hawn Johnson & Morrison of Minneapolis.

Tags: street journal allen wall

 
 

Centrify Named Silicon Valley Fastest Growing Private Company by Silicon Valley Business Journal

2013-10-16 06:00:00| Industrial Newsroom - All News for Today

Centrify Recognized as One of Silicon Valley&rsquo;s Top Private Companies after Posting Best-Ever Fiscal Year for Revenues and Bookings<br /> <br /> SUNNYVALE, Calif. &mdash; Centrify Corporation, the leader in Unified Identity Services across data center, cloud and mobile, today announced that it has been included on the Silicon Valley Business Journal&rsquo;s Fastest Growing Private Companies list for 2013. Centrify was honored last night at an awards banquet at the Computer History Museum ...

Tags: business company private journal

 

Results of Phase II PRECEDENT Trial for Investigational Folate Receptor Therapy Vintafolide in Patients with Platinum-Resistant Ovarian Cancer Published in Journal of Clinical Oncology

2013-10-14 23:02:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION N.J., & WEST LAFAYETTE, Ind. Merck and Endocytes Phase III PROCEED pivotal trial of vintafolide in ovarian cancer ongoing WHITEHOUSE STATION N.J., & WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology. Language: English Contact: MerckMedia:Caroline Lappetito,267-305-7639Caroline.Lappetito@Merck.comorClaire Mulhearn, 908-423-7425Claire.Mulhearn@Merck.comorInvestors:Carol Ferguson, 908-423-4465Carol.Ferguson@Merck.comorJustin Holko, 908-423-5088Justin_Holko@Merck.comorEndocyteMedia:Tony Russo, 212-845-4251Tony.Russo@Russopartnersllc.comorMartina Schwarzkopf, 212-845-4292Martina.Schwarzkopf@Russopartnersllc.comorInvestors:Stephanie Ascher, 212-362-1200Stephanie@sternir.com Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: ECYT Exchange: NASDAQ read more

Tags: of results journal published

 

Press Digest - Wall Street Journal - Oct 1

2013-10-02 05:19:06| Industrial Machines - Topix.net

The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

Tags: press street oct journal

 

Sites : [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] next »